TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9579961

Group type: EXPERIMENTAL
Intervention: 400 mg GBP oral dose in fasting state
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 800 mg GBP oral dose in fasting state
Number of subjects: 12

Group type: COMPARATOR
Intervention: 400 mg GBP oral dose after a high-protein meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: 800 mg GBP oral dose after a high-protein meal
Number of subjects: 12
Study: 8400077

Group type: EXPERIMENTAL
Intervention: Cellulosic membranes (CUP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncellulosic membranes (PAN, AN69)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncellulosic membranes (AN69)
Number of subjects: 0
Study: 3081081

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 29049890

Group type: EXPERIMENTAL
Intervention: Everyday Activity Supports You intervention (group-based intervention focusing on reducing sedentary behaviour, 6 months duration, nine 2-hour sessions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (monthly group-based health-related education sessions, 6 months duration, six 1-hour sessions)
Number of subjects: 20
Study: 25904498

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% ointment (CP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1% ointment (MMF)
Number of subjects: 48
Study: 25232073

Group type: EXPERIMENTAL
Intervention: Immediate weight-bearing from day one
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-weight-bearing for six weeks
Number of subjects: 30
Study: 22421983

Group type: EXPERIMENTAL
Intervention: GLP-1 treatment for 48 hours
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 11
Study: 19962701

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: allopurinol 300mg/day
Number of subjects: 60
Study: 18697846

Group type: EXPERIMENTAL
Intervention: Restricted randomization scheme
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Stratification and restriction
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Random allocation process
Number of subjects: 24
Study: 16670027

Group type: EXPERIMENTAL
Intervention: Provider education and fee-for-service reimbursement for delivering fluoride varnish and sealants
Number of subjects: 689

Group type: COMPARATOR
Intervention: Control group (no provider education and fee-for-service reimbursement)
Number of subjects: 689
Study: 12826783

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 5/10 mg (combination)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Enalapril 10 mg (conventional)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril (without HCTZ)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Enalapril (with HCTZ)
Number of subjects: 214
Study: 10982310

Group type: EXPERIMENTAL
Intervention: 10 microg PGE1 alone
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 10 microg PGE1 plus 1 mg PHE
Number of subjects: 116
Study: 8782726

Group type: EXPERIMENTAL
Intervention: Low fat diet ad libitum
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (no weight change)
Number of subjects: 66
Study: 1627943

Group type: EXPERIMENTAL
Intervention: Great-dose huanshao dan capsules
Number of subjects: 309

Group type: COMPARATOR
Intervention: Great-dose watered pills
Number of subjects: 309

Group type: COMPARATOR
Intervention: Small-dose watered pills
Number of subjects: 309

Group type: COMPARATOR
Intervention: Short-treating course group
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control group (group 6)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Huanshao dan and watered pills (combined)
Number of subjects: 309
Study: 6370979

Group type: EXPERIMENTAL
Intervention: Nomifensine (100 mg single daily dose)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 29941021

Group type: EXPERIMENTAL
Intervention: Fluralaner spot-on treatment (Bravecto®) at a dose rate of 40 mg/kg, administered topically on Day 0.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 20
Study: 27386742

Group type: EXPERIMENTAL
Intervention: Experimental group (received five in-school sessions)
Number of subjects: 1381

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 1381

Group type: COMPARATOR
Intervention: Control group (received no smoking prevention information)
Number of subjects: 1381
Study: 24714829

Group type: EXPERIMENTAL
Intervention: Glutamine alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glutamine plus vitamin A plus zinc
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (zinc plus vitamin A vehicle plus glycine)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glutamine alone and all combined nutrients (glutamine, vitamin A, and zinc)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glutamine treatment
Number of subjects: 120
Study: 24193155

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg induction infusions at weeks 0, 2, and 6
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg every 8 weeks (q8w)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Infliximab 10 mg/kg
Number of subjects: 60
Study: 20735290

Group type: EXPERIMENTAL
Intervention: Eltrombopag 50 mg
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Eltrombopag 75 mg
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Eltrombopag 100 mg
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study: 18489775

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus casei rhamnosus) administered at 10^9 colony-forming units twice daily from day 3 to discharge
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus casei rhamnosus)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 15899078

Group type: EXPERIMENTAL
Intervention: Nurse clinic
Number of subjects: 245

Group type: COMPARATOR
Intervention: Doctor clinic
Number of subjects: 245
Study: 12435983

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 60
Study: 10347518

Group type: EXPERIMENTAL
Intervention: Experimental alternating air device
Number of subjects: 217

Group type: COMPARATOR
Intervention: Conventional practice (Control)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control
Number of subjects: 217
Study: 7572708

Group type: EXPERIMENTAL
Intervention: Beta formula (triacylglycerols resembling the stereoisomeric structure of human milk fat, 25.4% by wt 16:0, 76.1% at the sn-2 position)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Alpha formula (87.3% of total 16:0, 25.7% by wt at the sn-1,3 positions)
Number of subjects: 7
Study: 1768431

Group type: EXPERIMENTAL
Intervention: Beta‐methasone‐17‐valerate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prednicarbate (two concentrations)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clobetasol‐17‐propionate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Betamethasone‐17,21‐dipropionate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Desoximetasone (DOM) in different biopharmaceutical forms
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DOM gel
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ointments
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Creams
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gels
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Visual scores
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Skin colorimetry
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia after arterial occlusion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resting skin blood flow in inflamed skin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Changes in temperature of inflamed skin
Number of subjects: 30
Study: 7129720

Group type: EXPERIMENTAL
Intervention: Counter-movement jump (CMJ) with active stretching of calf muscles before concentric work
Number of subjects: 5

Group type: COMPARATOR
Intervention: Pure concentric contraction (SJ)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: EMG recording during CMJ
Number of subjects: 5
Study: 31513849

Group type: EXPERIMENTAL
Intervention: WM updating training (adaptive dual n-back task)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active control (computer game)
Number of subjects: 40
Study: 28099699

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic hysterectomy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard laparoscopic hysterectomy
Number of subjects: 144
Study: 25712532

Group type: EXPERIMENTAL
Intervention: Ethanol (wine)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ethanol (vodka)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dealcoholized wine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 24875964

Group type: EXPERIMENTAL
Intervention: Preoperative pain neuroscience education (NE) plus usual care (UC)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 67
Study: 21789590

Group type: EXPERIMENTAL
Intervention: S(3) Bond (Kuraray Corp., Japan) with Clearfil ST resin composite
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: G‐Bond (GC Corp., Japan) with Gradia resin composite
Number of subjects: 11
Study: 20025139

Group type: EXPERIMENTAL
Intervention: Triple phototherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Double phototherapy
Number of subjects: 40
Study: 17446812

Group type: EXPERIMENTAL
Intervention: Interval training (n=11; 100% of peak work rate for 30 s, alternating with 30 s-rest)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Continuous training (n=10; 50% of peak work rate)
Number of subjects: 21
Study: 15539725

Group type: EXPERIMENTAL
Intervention: FANO in patients with PBC associated with SS (mean 8.9 ± 0.8 ppb)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: FANO in patients with PBC not associated with SS (mean 7.7 ± 0.7 ppb)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: FANO in cirrhotic patients with increased P(A-a)O(2) (mean 9.8 ± 0.8 ppb)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: QbrNO in patients with primary SS and SS associated with PBC
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control subjects (healthy controls)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Patients with primary SS
Number of subjects: 34
Study: 11429344

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (initial dose of 10 mg/kg and infusion of 1 mg/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 40
Study: 10937295

Group type: EXPERIMENTAL
Intervention: Phonological awareness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rapid naming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral decoding of words and pseudowords
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pseudoword reading
Number of subjects: 0
Study: 9305673

Group type: EXPERIMENTAL
Intervention: CIFN 9 microg
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: CIFN 3 microg
Number of subjects: 704

Group type: COMPARATOR
Intervention: Interferon alfa‐2b 3 MU
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: CIFN 15 microg
Number of subjects: 704
Study: 8452273

Group type: EXPERIMENTAL
Intervention: VCRII technique using 4.5% sevoflurane in nitrous oxide and oxygen
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional spontaneous inhalation induction technique using 4.5% sevoflurane in nitrous oxide and oxygen
Number of subjects: 64
Study: 3699074

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 31881929

Group type: EXPERIMENTAL
Intervention: Renal denervation via cryoablation (Cryo-RDN)
Number of subjects: 0
Study: 29277689

Group type: EXPERIMENTAL
Intervention: Jet Nebulizer (JN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Breath-Enhanced Nebulizer (BEN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vibrating Mesh Nebulizer (VMN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Manually Triggered Nebulizer (MTN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Breath-Actuated Nebulizer (BAN)
Number of subjects: 10
Study: 27405396

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding intervention promoted by peer counsellors during the first 6 months of infancy
Number of subjects: 765
Study: 24169807

Group type: EXPERIMENTAL
Intervention: Linagliptin added to sulphonylurea
Number of subjects: 619

Group type: COMPARATOR
Intervention: Placebo added to sulphonylurea
Number of subjects: 619
Study: 21707252

Group type: EXPERIMENTAL
Intervention: Telephone-assisted coping planning intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Self-administered coping planning intervention
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Coping plans formulated
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Goal-pursuit strategies (optimisation and compensation)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Coping plans and goal-pursuit strategies interaction
Number of subjects: 86
Study: 20629867

Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO(2)) treatment (0% at 96 h, 60% at 48 h, and 60% at 96 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ozone (O(3)) treatment (0 and 175 ppm for 48 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study: 18589630

Group type: EXPERIMENTAL
Intervention: Acute psychiatric day care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Socio-demographic and clinical characteristics analysis
Number of subjects: 0
Study: 15844692

Group type: EXPERIMENTAL
Intervention: OACA (omeprazole‐amoxicillin‐clarithromycin + aspirin)
Number of subjects: 121

Group type: COMPARATOR
Intervention: OAC (omeprazole‐amoxicillin‐clarithromycin)
Number of subjects: 121
Study: 12433016

Group type: EXPERIMENTAL
Intervention: Nurse-administered educational and behavioral intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard-treatment (education) control group
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 10069685

Group type: EXPERIMENTAL
Intervention: Lacidipine, 4 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Short-acting nifedipine, 20 mg
Number of subjects: 29
Study: 7628131

Group type: EXPERIMENTAL
Intervention: simvastatin 10 mg PO QPM
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: simvastatin 20 mg PO QAM
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: simvastatin 20 mg PO QPM
Number of subjects: 343

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 343
Study: 1838693

Group type: EXPERIMENTAL
Intervention: 2.5 mg cilazapril
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 5 mg cilazapril
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 30303061

Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Mentalisation-based therapy (MBT)
Number of subjects: 90
Study: 27609792

Group type: EXPERIMENTAL
Intervention: 18F‐fluciclovine PET/CT
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional imaging (CT and MRI)
Number of subjects: 96
Study: 26558544

Group type: EXPERIMENTAL
Intervention: Once daily (q.d.) lopinavir/ritonavir
Number of subjects: 173

Group type: COMPARATOR
Intervention: Twice daily (b.i.d.) lopinavir/ritonavir
Number of subjects: 173
Study: 23646932

Group type: EXPERIMENTAL
Intervention: ICG-augmented diode laser treatment (ICG+DL) with λem = 810 nm, 60-110 J cm(‐2), 48-87-ms pulse duration, 6-mm spot size; total ICG dose 4 mg kg(‐1)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Nd:YAG laser treatment with λem = 1064 nm, 160-240 J cm(‐2), 65-ms pulse duration, 5-mm spot size
Number of subjects: 29
Study: 21468375

Group type: EXPERIMENTAL
Intervention: Submucous resection of a hypertrophied inferior turbinate together with septoplasty (Group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Septoplasty only (Group B)
Number of subjects: 42
Study: 18068828

Group type: EXPERIMENTAL
Intervention: Edmonton Frail Scale (EFS) score of 3 or less
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Edmonton Frail Scale (EFS) score exceeding 7
Number of subjects: 125
Study: 18163135

Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Microscopy (local laboratory)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Microscopy (reference laboratory)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Clinical diagnosis (all symptoms)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Clinical diagnosis (fever alone)
Number of subjects: 89
Study: 15194018

Group type: EXPERIMENTAL
Intervention: Co-administration of 10/10 mg ezetimibe + simvastatin
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Co-administration of 10/80 mg ezetimibe + simvastatin
Number of subjects: 788
Study: 11464718

Group type: EXPERIMENTAL
Intervention: Melatonin levels measured at 8 a.m.
Number of subjects: 0
Study: 9568167

Group type: EXPERIMENTAL
Intervention: Combined therapy of G‐CSF and GM‐CSF at 10 mcg/kg/day (2.5 or 5.0 mcg/kg twice per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy with G‐CSF or GM‐CSF at 5 mcg/kg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy with G‐CSF or GM‐CSF at 10 mcg/kg/day
Number of subjects: 0
Study: 8041179

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (300 mg dl-alpha-tocopherol 3 times daily for 4 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin E and Placebo)
Number of subjects: 18
Study: 2594875

Group type: EXPERIMENTAL
Intervention: amitriptyline
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 45
Study: 1200770

Group type: EXPERIMENTAL
Intervention: Behavior therapists
Number of subjects: 60

Group type: COMPARATOR
Intervention: Psychotherapists
Number of subjects: 60
Study: 31820131

Group type: EXPERIMENTAL
Intervention: Modified-release (MR) drug product with a proposed change in dissolution specification; specific dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothetical formulation with 0% of drug dissolved in 2 hours in in vitro dissolution test; specific dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBPK absorption model; specific dosage and duration not available.
Number of subjects: 0
Study: 30221578

Group type: EXPERIMENTAL
Intervention: Adaptive computerized cognitive flexibility training (frequent or infrequent switching)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study: 29045327

Group type: EXPERIMENTAL
Intervention: Young women in dry heat (35°C, 20% relative humidity)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Older women in dry heat (35°C, 20% relative humidity)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Older women in humid heat (35°C, 60% relative humidity)
Number of subjects: 20
Study: 25916595

Group type: EXPERIMENTAL
Intervention: Air temperature at 32 °C with relative humidity greater than 57.8%
Number of subjects: 68

Group type: COMPARATOR
Intervention: Air temperature at 24 °C
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lower levels of physical activity (<4 times per week)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Heat stress
Number of subjects: 68
Study: 24460248

Group type: EXPERIMENTAL
Intervention: BSE education from healthcare professionals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21921700

Group type: EXPERIMENTAL
Intervention: Indian tetravalent vaccine (Q-Vac (TM))
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: European tetravalent vaccine (Tritanrix-HB (TM))
Number of subjects: 287
Study: 19697853

Group type: EXPERIMENTAL
Intervention: Lymphotrophic chemoimmunotherapy with roncoleukin
Number of subjects: 0
Study: 17039460

Group type: EXPERIMENTAL
Intervention: Isomalt (30 g per day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sucrose (30 g per day)
Number of subjects: 19
Study: 14977341

Group type: EXPERIMENTAL
Intervention: Intravenous anaesthesia with propofol-remifentanil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Balanced anaesthesia with isoflurane-alfentanil
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Quality of Recovery score and patient satisfaction
Number of subjects: 120
Study: 10700773

Group type: EXPERIMENTAL
Intervention: Active enforcement of DVT prophylaxis protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-enforced DVT prophylaxis protocol
Number of subjects: 0
Study: 9328361

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 30
Study: 7691912

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo transdermal nicotine
Number of subjects: 12
Study: 2430512

Group type: EXPERIMENTAL
Intervention: 3-day therapy with nalidixic acid
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 3-day therapy with trimethoprim/sulphamethoxazole
Number of subjects: 35

Group type: COMPARATOR
Intervention: 10-day therapy with nalidixic acid
Number of subjects: 35

Group type: COMPARATOR
Intervention: 10-day therapy with trimethoprim/sulphamethoxazole
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Short-term treatment (3-day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional treatment (10-day)
Number of subjects: 35
Study: 31122495

Group type: EXPERIMENTAL
Intervention: BIIB092 150 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BIIB092 700 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BIIB092 2100 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 28549427

Group type: EXPERIMENTAL
Intervention: Let's Talk about Children
Number of subjects: 192

Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 192